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Risk Factors for Progression of Carotid Intima-Media
Thickness and Total Plaque Area
A 13-Year Follow-Up Study: The Tromsø Study
Marit Herder, MD; Stein Harald Johnsen, MD, PhD;
Kjell Arne Arntzen, MD; Ellisiv B. Mathiesen, MD, PhD
Background and Purpose—Data on risk factors for progression of intima-media thickness (IMT) and plaque are scarce.
The objective was to determine long-term risk factors for total plaque area (TPA) and IMT as well as risk factors for
progression (TPA and IMT).
Methods—Subjects were 1307 men and 1436 women who participated in a longitudinal population-based study with
ultrasound examination of the right carotid artery at baseline and after 13 years of follow-up. Total cholesterol,
high-density lipoprotein cholesterol, blood pressure, body mass index, and information about smoking habits, prevalent
diabetes, and cardiovascular disease were obtained at baseline. Carotid atherosclerosis was assessed as TPA and mean
IMT of plaque-free segments of the common carotid artery. Associations between z-scores of risk factors and carotid
atherosclerosis were assessed in multiple linear regression models.
Results—In multivariable models, total cholesterol, systolic blood pressure, and smoking were stronger predictors of
follow-up TPA than of IMT, whereas sex and age were stronger predictors of IMT. Total cholesterol (standardized
0.081), systolic blood pressure (standardized 0.062), and smoking (standardized 0.107) were significant
predictors of TPA, whereas only total cholesterol (standardized 0.084) was an independent predictor of IMT. The
variance explained by traditional cardiovascular risk factors was somewhat greater for TPA than for IMT.
Conclusions—The cardiovascular risk factors total cholesterol, smoking, and systolic blood pressure were stronger
long-term predictors of TPA and TPA progression than for IMT and IMT progression. (Stroke. 2012;43:1818-1823.)
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Carotid intima-media thickness (IMT) and plaque arefrequently used as a proxy for cardiovascular diseases in
observational and interventional studies.1–3 However, in re-
cent years it has been come increasingly clear that IMT and
plaque show different relationships to cardiovascular risk
factors as well as clinical end points. According to guidelines,
IMT is preferably measured in plaque-free segments of the far
wall of the distal common carotid artery (CCA-IMT).4
CCA-IMT is strongly related to age and hypertension, and
thickening of the intima-media layer mainly represents a
hypertrophic adaptive response of smooth muscle cells in the
tunica media to high shear stress.5,6 Plaques usually occur at
sites of low shear and nonlaminar turbulent flow such as in
the carotid bulb and the proximal internal carotid artery,6 and
is rare in the distal CCA. The role of IMT as a marker of
atherosclerosis has been questioned, especially when mea-
surements include the CCA-IMT only.7 Carotid plaque bur-
den can be measured as a continuous variable as the sum of
all plaque areas in the artery, the total plaque area (TPA).
TPA has been found to be more strongly associated with
traditional cardiovascular risk factors than CCA-IMT.5,8 TPA
has also been found to be a stronger predictor of coronary
artery disease than CCA-IMT in both clinical and population-
based studies.9–12 In a recent publication from our group,
IMT was predictive of ischemic stroke in women when
assessed as an average of the mean IMT in the far and near
wall of the common carotid and in the far wall of the
bifurcation and with plaques included. However, CCA-IMT
was not associated with future ischemic stroke after adjust-
ment for other cardiovascular risk factors.13 Although highly
correlated, plaque and IMT may reflect different genetic and
biological aspects of atherogenesis with distinctive relations
to cardiovascular risk factors and to clinical vascular disease.
Data on risk factors for progression of both IMT and
plaque are scarce. In the population-based Tromsø Study, we
have done repeated measurements of both IMT and TPA in
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the same individuals, and the study is therefore well suited to
assess the impact of different cardiovascular risk factors on
progression of the 2 ultrasonographic phenotypes. In the
present prospective study, the objective was to determine risk
factors for TPA and IMT at follow-up as well as risk factors
for progression (TPA and IMT).
Materials and Methods
Subjects
The Tromsø Study is a population-based prospective study with
repeated health surveys of inhabitants in the municipality of Tromsø,
Norway.14 In the fourth survey in 1994 to 1995 (baseline), all
subjects aged 55 to 74 years and a random 5% to 10% sample in the
other age groups 24 years were invited to ultrasound scanning of
the carotid artery. Ultrasound of the right carotid artery was
performed in 6727 subjects (77% of the eligible). Subjects who did
not consent to medical research (n40) were excluded. Representa-
tive measures of TPA and CCA-IMT were available in 6611
participants, 3271 men and 3340 women. All participants who were
still living in Tromsø were invited to a new examination in the sixth
survey in 2007 to 2008 (follow-up). Ultrasound examination of the
right carotid artery was performed in 2975 persons who had
attended both the fourth and the sixth surveys. We excluded
persons without valid measures on all risk factor variables as well
as the outcome variables (n87) and 145 subjects with plaque in
the distal CCA (see subsequently), leaving 2743 persons to be
included in the study. The Regional Committee for Medical
Research Ethics approved the study, and informed written consent
was obtained from all the participants.
Cardiovascular Risk Factors
Information about smoking habits, prevalent diabetes mellitus, an-
gina pectoris, previous myocardial infarction, stroke, and current use
of antihypertensive- and lipid-lowering drugs was collected from
self-administered questionnaires. Coronary heart disease was defined
as previous myocardial infarction and/or prevalent angina, and
cardiovascular disease as previous myocardial infarction and/or
prevalent angina and/or stroke. Blood pressure was recorded 3 times
at 1-minute intervals after 2 minutes of seated resting with the use of
an automatic device (Dinamap Vital Signs Monitor 1846l Criticon)
and by specially trained technicians. The mean of the last 2
recordings was used in the report. Standardized measurements of
height, weight, nonfasting serum total cholesterol, high-density
lipoprotein cholesterol, and triglycerides were performed as de-
scribed previously.13 Body mass index (BMI) was calculated as
weight (kg) divided by height (m2).
Ultrasonography
High-resolution B-mode ultrasonography of the right carotid artery
was at baseline performed with a duplex scanner (Acuson Xp10 128,
ART-upgraded) equipped with a 7.5-MHz linear array transducer
and at follow-up with a duplex scanner GE Vivid 7 with a linear
12-MHz transducer and followed the same scanning and reading
procedures and reproducibility as published previously.15,16 Differ-
ent sonographers did the baseline and follow-up scanning, and to
ensure equal and standardized examination techniques and measure-
ment procedures, all sonographers completed a 2-month prestudy
training protocol.
A plaque was defined as a localized protrusion of the vessel wall
into the lumen of at least 50% compared with the adjacent IMT. Six
locations of the carotid artery were examined for plaque presence:
the far walls and near walls of the CCA, the bifurcation (bulb), and
the internal carotid artery. The area of each plaque was outlined
manually with automatic calculation of plaque area. In subjects with
1 plaque, the areas of all plaques were summarized to give TPA.
Automated R-triggered measurement of IMT was performed in the
far wall of the distal CCA16 and was not limited to plaque-free
segments. To ensure that the CCA-IMT measurements were done in
plaque-free segments only,4 we excluded subjects with plaque in the
distal CCA (n145). A final reading of both IMT and plaque data
was done offline by the researchers. Measurements of IMT were
analyzed offline by a semiautomated computerized edge-detection
program.17 The average of the mean CCA-IMT in 3 separate
recordings was used in the analyses and is referred to as IMT.
Details about the inter- and intraobserver reproducibility of IMT
and plaque measurements have been published previously.15,16,18 The
interequipment variability between GE Vivid 7 and Acuson XP10
was tested in 79 subjects, of whom 38 had 1 plaques. All subjects
were examined with Acuson XP10 first. To minimize the influence
of sonographer and reader variability, all examinations were per-
formed by the same sonographer, whereas the readings of TPA and
IMT were done by another person blinded to the identity of the
participants. IMT values were higher when measured with GE Vivid
7 compared with Acuson XP10 with a mean arithmetic difference of
0.15 mm (95% CI, 0.14–0.17 mm). The mean absolute difference
was 0.16 mm, coefficient of variation 9.1%, and the limits of
agreement 0.20 mm. For TPA, the mean absolute difference was
6.5 mm2 and the mean arithmetic difference 2.4 mm2 (95% CI, 0.5
to 5.4), indicating no systematic difference between machines. The
coefficient of variation was 26.4% and the correlation coefficient
0.89. Limits of agreement was not calculated due to skewed
distribution of the arithmetic differences. For the square root-
transformed TPA values, which was used in the analyses (see
subsequently), the mean arithmetic difference was 0.2 (95% CI,
0.06 to 0.50), the mean absolute difference 0.68, the coefficient of
variation 13.2%, and limits of agreement 1.7.
Statistical Analyses
Between-group differences were estimated by analysis of variance
(Table 1). The distribution of TPA was skewed to the right and the
square root of this variable was used in the analyses to approximate
normal distribution. The independent relationship between cardio-
vascular risk factors (independent variables) and measurements of
atherosclerosis (TPA and IMT at follow-up and TPA and IMT)
was assessed in multiple linear regression models with all explana-
tory variables entered stepwise using the forward selection method.
Additional adjustments were made for use of antihypertensive and
lipid-lowering drugs at baseline. All variables, both dependent and
independent, were standardized using z-scores to compare the
Table 1. Characteristics* of the Study Participants Stratified





Age, y 55.8 (9.08) 56.6 (10.2) 0.03
BMI, kg/m2 26.1 (3.0) 25.6 (3.91) 0.001
Systolic blood pressure, mm Hg 139.8 (17.9) 138.4 (21.67) 0.07
Serum lipids, mmol/L
Total cholesterol 6.51 (1.15) 6.69 (1.32) 0.0001
HDL cholesterol 1.38 (0.37) 1.70 (0.40) 0.0001
Triglycerides 1.79 (1.12) 1.42 (0.85) 0.0001
Current smoking, % 28.2 27.2 0.6
Self reported disease, %
Coronary heart disease 8.8 4.3 0.001
Stroke 0.8 1.1 0.5
Diabetes 1.2 1.6 0.4
Use of drugs, %
Antihypertensive medication 7.7 8.8 0.3
Lipid-lowering therapy 2.1 1.0 0.021
*Measured at baseline.
BMI indicates body mass index; HDL, high-density lipoprotein.
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strength of the  coefficients of each independent variable. The
summarized and partial R2 of the models were used to calculate the
proportion of the explained variance associated with each indepen-
dent variable. The significance level for entry into the model was set
at 0.05. SAS software, Version 9, and STATA software, Version 12,
were used for statistical analyses. Two-sided probability values
0.05 were considered statistically significant.
Results
The mean observation time was 13.2 years. Baseline character-
istics are shown in Table 1. Men had higher BMI, higher
triglyceride, and lower high-density lipoprotein levels than
women and a higher proportion of men reported coronary heart
disease, use of lipid-lowering drugs, and current smoking.
Plaque was present in 41.6% of men and 32.6% of women at
baseline. Mean TPA was 7.41 (SD 12.60) mm2 in men and 4.73
(SD 9.73) mm2 in women (Table 2). Mean IMT was higher in men
(mean, 0.73; SD 0.16 mm) than in women (0.69; SD 0.13 mm).
During follow-up, the overall progression of TPA was
10.84 mm2 in men and 7.42 mm2 in women (P0.0001;
Table 2). In all age groups, TPA and TPA were greater in
men than in women (Figures 1 and 2). Regression in TPA was
found in 11% of women (mean, 8.96 mm2) and 14% of men
(mean, 11.48 mm2). Plaque growth increased by age in both
men and women and more rapidly after the age of 50 years,
whereas the progression rate of IMT was constant over time
(Table 2; Figure 2). The annual progression rate of IMT was
0.012 mm in men and 0.011 mm in women. Regression in
IMT was found in 13% of women (mean, 0.097 mm) and
13.4% of men (mean, 0.104 mm). Although IMT levels at
baseline and follow-up increased by age, no correlation was
found between IMT and age (Table 2; Figure 2).
In a stepwise multivariable regression model, age, sex,
total cholesterol, systolic blood pressure, smoking, prevalent
cardiovascular disease, and use of lipid-lowering drugs were
independent predictors of TPA at follow-up (Table 3). The
model R2 was 0.19. Age accounted for 53% of the explained
variance, smoking and sex 11% each, total cholesterol 10%,
systolic blood pressure 7%, lipid-lowering drugs 4%, and
cerebrovascular disease 1% (calculated from the partial and
summarized R2; Table 3). Age, sex, total cholesterol, high-
density lipoprotein cholesterol, systolic blood pressure, BMI,
and smoking were independent predictors of IMT at
follow-up (model R2 0.21; Table 3). Age explained 71% of
the explained IMT variance, sex 19%, BMI 5%, total choles-
terol 2%, and systolic blood pressure, smoking, and high-
density lipoprotein cholesterol 1% each.
Age, sex, smoking, total cholesterol, systolic blood pres-
sure, and use of lipid-lowering drugs were independent
Table 2. Mean Intima-Media Thickness* and Total Plaque Area at Baseline and Progression Between
Baseline and Follow-Up by Age and Sex: The Tromsø Study
Progression
Baseline IMT, mm TPA, mm2
No. IMT, mm TPA, mm2 Total Annual Total Annual
Men
25–49 y 243 0.63 2.60 0.14 0.01 2.32 0.18
50–59 y 531 0.73 6.34 0.18 0.01 7.25 0.55
60–69 y 466 0.78 10.31 0.17 0.01 7.37 0.58
70 y 67 0.85 13.39 0.15 0.01 13.52 1.02
Total 1307 0.73 7.42 0.16 0.01 10.84 0.82
Women
25–49 y 257 0.59 0.71 0.11 0.01 1.39 0.11
50–59 y 488 0.68 3.63 0.12 0.01 1.79 0.14
60–69 y 594 0.73 6.18 0.13 0.01 5.28 0.4
70 y 98 0.79 12.01 0.15 0.01 9.09 0.69
Total 1437 0.69 4.73 0.14 0.01 7.42 0.56
*Mean of 3 measurements in plaque-free segments in the far wall of the distal common carotid artery.
IMT indicates intima-media thickness; TPA, total plaque area.
Figure 1. A–B, IMT and TPA at follow-up by sex and age group.
IMT indicates intima-media thickness; TPA, total plaque area.
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predictors of progression of TPA (Table 4). Age accounted
for 39% of the explained variance, smoking 29%, total
cholesterol 12%, sex 9%, systolic blood pressure 7%, and
lipid-lowering therapy 5% (Table 4). Sex and total cholesterol
were associated with progression of IMT (Table 4), whereas
systolic blood pressure showed an inverse relationship (stan-
dardized  0.076). None of the other cardiovascular risk
factors predicted IMT progression.
Discussion
The main finding of the present study was that age, total
cholesterol, systolic blood pressure, and smoking predicted
progression of TPA, whereas only total cholesterol was a
predictor of IMT progression. The variance explained by
traditional cardiovascular risk factors was somewhat greater
for TPA than for IMT.
Few studies have assessed risk factors for progression of
IMT and plaque, and to the best of our knowledge, data on
progression of TPA and IMT in the same individuals have not
been published previously. In the Rotterdam study, current
smoking was the strongest predictor of increase in plaque
number.19 Strong associations were also found for age, total
cholesterol, hypertension, and systolic blood pressure,
whereas only age and BMI predicted progression of IMT
consistently.19 In the Atherosclerosis Risk in Communities
Study (ARIC), diabetes, current smoking, high-density lipo-
protein cholesterol, pulse pressure, white blood cell count,
and fibrinogen were predictors of IMT progression.20 In a
Finnish population-based study in men, age, serum low-
density lipoprotein cholesterol, pack-years of smoking, blood
leukocyte count, and platelet aggregability were the strongest
predictors of CCA-IMT progression. Hypertension, blood
pressure, and high-density lipoprotein cholesterol did not
show any association with progression of IMT over 2 years.21
Surprisingly, systolic blood pressure was negatively asso-
ciated with IMT progression despite the fact that systolic
blood pressure was a strong predictor of follow-up IMT.
These findings are confusing when comparing previous
reports that highlight age and hypertension as major risk
factors of intima media thickening. However, previous stud-
ies have failed to find significant associations between
systolic blood pressure and/or hypertension and progression
of IMT.19–21 Larger within-person variance of progression of
IMT than of cross-sectional IMT can be expected to result in
stronger estimates for cross-sectional analyses compared with
longitudinal.20
Increased use of statins during the follow-up period may
have affected the associations between risk factors and the
dependent variables. Use of statins in the population was very
Figure 2. A–B, Change in IMT and TPA from baseline to
follow-up by sex and age group. IMT indicates intima-media
thickness; TPA, total plaque area.
Table 3. Predictors of IMT and TPA at Follow-Up in Stepwise Multivariable Regression Analysis: The
Tromsø Study
IMT TPA*
† r2 P Value † r2 P Value
Age, y 0.359 0.145 0.0001 0.263 0.099 0.0001
Male sex 0.177 0.039 0.0001 0.136 0.020 0.0001
Total cholesterol, mmol/L 0.066 0.004 0.0001 0.125 0.019 0.0001
HDL cholesterol, mmol/L 0.049 0.002 0.011 … … …
Systolic blood pressure, mm Hg 0.041 0.001 0.003 0.126 0.014 0.0001
Body mass index, kg/m2 0.081 0.011 0.0001 … … …
Smoking 0.054 0.003 0.002 0.165 0.026 0.0001
Use of lipid-lowering drugs … … … 0.075 0.007 0.0001
Cardiovascular disease … … … 0.045 0.002 0.0001
Diabetes … … … … … …
Summarized model R2 0.206 0.186
IMT indicates intima-media thickness, TPA; total plaque area; HDL, high-density lipoprotein.
*Square root transformed.
†Standardized regression  coefficients; z-scores for all independent and dependent variables.
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low (2%) at baseline but increased to 11.8% during follow-
up. Lipid-lowering therapy at baseline was positively associ-
ated with progression of TPA, and this variable probably acts
as a marker of increased cardiovascular risk.
In our study, the annual progression of IMT was 0.012 mm
in men and 0.011 mm in women, which is somewhat less than
the progression of mean IMT of approximately 0.015 mm in
previous reports.22 Regression of IMT was found in approx-
imately 13% of the study group. Interestingly, the progression
rate of TPA increased by age, whereas progression of IMT
was constant over age groups. This may explain why age was
a significant risk factor for progression of TPA but not for
IMT.
Plaque and IMT may represent different phenotypes of
atherosclerosis with differential relations to cardiovascular
risk factors and to clinical vascular disease.5,9,23 Both autopsy
studies and ultrasonographic studies have demonstrated that
carotid plaque is more strongly correlated to atherosclerosis
in other vascular beds than is IMT.24–30 This probably reflects
differences in the pathological processes leading to intima-
media thickening of the distal part of CCA and plaque
formation in other arteries, whereas plaque formation in the
carotid artery and other arterial beds is more closely related.7,8
Thickening of the intima-media layer in CCA is usually
caused by hypertrophy of the smooth muscle cells in the
media layer, whereas the atherosclerotic process, particularly
in its early phase, is restricted to the intimal layer. Athero-
sclerotic plaque formation represents a later stage of athero-
genesis related to oxidation of lipids, transmigration and
infiltration of monocytes, and lymphocytes, inflammation,
and smooth muscle cell proliferation.5 Longitudinally plaque
growth along the carotid axis of flow is 2 times faster than
thickening toward the lumen.31 Thus, TPA provides more
detailed information of the atherosclerotic burden than IMT.
Measuring plaque on a continuous scale increases the ability
to quantify the effect of and interaction among risk factors
compared with categorical classification.32
Measuring progression of atherosclerosis is more difficult
than single measurements because random measurement
errors at baseline and follow-up are accumulated, tending to
attenuate the differences aimed to be detected. In the Asymp-
tomatic Carotid Artery Progression Study, variance compo-
nent analyses revealed that 11% of the total variance of IMT
was attributable to systematic differences among readers,
nonvisualization contributed 7%, whereas the predominant
source of error was random, including any drift, nonlinearity,
and sonographer differences.33 From an imaging technology
perspective, it should be emphasized that IMT is a very small
structure, usually a fraction of a millimeter, and changes over
time represents only tenths of millimeter, that is, the resolu-
tion of the B-mode image is below the quantities being
measured. This makes the method less suitable for longitu-
dinal measurements at an individual level. Although the large
number of readings will tend to counteract the inherent
measurement errors, it may still be questioned whether IMT
progression at a group level can be reliably measured in
epidemiological studies. Reproducibility in observational
studies not a priori set up to assess IMT change over time has
usually been much lower (intraclass correlation of repeated
measurement of 0.59–0.75) than in trials (intraclass correla-
tion 0.90).34 In our study, measurements were performed on
the right carotid artery only, and examination of both carotid
arteries could have yielded more precise estimates of the
individual’s IMT and total carotid plaque burden. Further-
more, different sonographers, readers, and ultrasound equip-
ment at baseline and follow-up represent methodological
weaknesses, which may have affected the precision and
reproducibility of the IMT and TPA measurements. This
could result in imprecise estimation of the true relationship
between risk factors and IMT and TPA. We found that
IMT was thicker when measured by Vivid 7 compared with
Acuson XP10, indicating that lack of association between risk
factors and IMT was not due to underestimation of the true
IMT levels. No systematic bias was found for TPA mea-
Table 4. Predictors of Change in IMT and TPA in Stepwise Multivariable Regression Analysis: The
Tromsø Study
IMT TPA*
† r2 P Value † R2 P Value
Age, y … … … 0.103 0.015 0.0001
Male, sex 0.067 0.004 0.0002 0.054 0.004 0.002
Total cholesterol, mmol/l 0.050 0.002 0.0002 0.067 0.005 0.0003
HDL cholesterol, mmol/L … … … … … …
Systolic blood pressure, mm Hg 0.076 0.004 0.002 0.056 0.003 0.0006
BMI, kg/m2 … … … … … …
Smoking … … … 0.106 0.011 0.0001
Use of lipid-lowering drugs … … … 0.041 0.002 0.03
Cardiovascular disease … … … … … …
Diabetes … … … … … …
Summarized model R2 0.010 0.038
IMT indicates intima-media thickness, TPA; total plaque area; HDL, high-density lipoprotein; BMI, body mass index.
*Square root transformed.
†Standardized regression  coefficients; z-scores for all independent and dependent variables.
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surements. Both the fact that plaques are larger structures and
the increasing progression rate of TPA by age may make
plaques more robust against this kind of measurement
variability.
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